Navigation Links
Pfizer Inc and GoIndustry DoveBid Partner to Auction Surplus Equipment from R&D Facilities Across the United States
Date:6/30/2010

BALTIMORE, June 30 /PRNewswire/ -- GoIndustry DoveBid announces the Pfizer asset disposition program, which will see auctions of surplus assets from Pfizer's facilities across the United States. Over 500 lots per week will be available via online auction as part of GoIndustry DoveBid's ongoing BioPharma Exchange, over the upcoming months.

(Logo: http://photos.prnewswire.com/prnh/20100630/PH28915LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20100630/PH28915LOGO )

Each week's auction will include an outstanding selection of assets ranging from HPLC and NMR Systems to Mass Spectrometers and general lab equipment. The majority of assets come from working environments and have been maintained, as one would expect from a top tier company such as Pfizer.

"With GoIndustry DoveBid, we have undergone an extensive project to identify all the surplus assets in our facilities across the country," said Bill Carr, Asset Disposition Director, from Pfizer Inc. "We have been pleased with our past results and look forward to our upcoming participation in the BioPharma Exchange."

The GoIndustry DoveBid BioPharma Exchange is a weekly series of online auction sales. Buyers typically have 24 to 48 hours to bid on state-of-the-art, biotech lab, research & development, and pharmaceutical equipment from the world's leading pharmaceutical manufacturers including Pfizer, Merck, and Bristol-Myers Squibb Company.

The BioPharma exchanges -- featuring high quality Pfizer equipment -- are conducted weekly. For more information visit http://www.go-dove.com/exchanges/BioPharma.

To learn more about the Pfizer equipment available, contact Tom Laster at tom.laster@go-dove.com or telephone: +1 (650) 377-2646

Further information and interviews available on request

About GoIndustry DoveBid & Pfizer

GoIndustry DoveBid continues to provide asset management services for Pfizer, supporting the company's ongoing global assets recovery efforts. As a result of this relationship, Pfizer has reduced the number of surplus assets; experienced cost savings due to internal redeployment of equipment globally; and benefited from welcome cash injections from external sales. Over the past 7 years, several business units -- from Animal Health to Pfizer Global Research & Development and Global Manufacturing -- have taken advantage of this full service relationship.

GoIndustry DoveBid works with the business units to help identify surplus assets. Our expert team provides market intelligence to facilitate whether the assets are made available for redeployment internally, or for sale externally. At which point assets are appraised to give an indication their market value.

GoIndustry DoveBid offers a wide range of options for external sale including: online Auction, Private Treaty sales, or industry specific Exchanges -- a weekly series of online auction sales. Pfizer continues to be a major player in the weekly BioPharma Exchange.

About GoIndustry DoveBid

GoIndustry DoveBid is a leading provider of asset management services. If surplus or idle assets are no longer needed, we help organizations understand their worth, whether they can be re-deployed elsewhere in the business, or sell them on the used industrial goods marketplace.

GoIndustry DoveBid approaches the market with three distinct advantages. First, we have significant global reach so we are able to provide these services wherever they are needed. Second, most of our business is online, making it more efficient and convenient for both buyers and sellers whether it's for a single piece of equipment or a whole production line. Third, our knowledge of the market across multiple industry sectors is unsurpassed. Since 2000, we have collected information gathered from auctions all over the world. We leverage this rich data on a daily basis through accurate valuations and appraisals for the benefit of all our customers.

Find out more about us at www.go-dove.com or contact us to unlock the value of your assets.


'/>"/>
SOURCE GoIndustry DoveBid
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizer Invites Public to View and Listen to Webcast of August 3 Conference Call With Analysts
2. Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg®
3. Pfizer And Epocrates Partner To Give Healthcare Providers Access To Medical Information Specialists For Medication Questions
4. Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
5. Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
6. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
7. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
8. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
9. President of Pfizer Vaccines, Mark Swindell, Named as the Healthcare Businesswomens Associations 2010 Honorable Mentor
10. VetCentric Announces Partnership With Pfizer Animal Health
11. Pfizer Selects ChemAxons Markush Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):